A database of FDA approved therapeutic peptides and proteins
ID1022 | ThPPIDTh1003 | NameDornase alfa | Peptide SequenceLKIAAFNIQTFGETKMSNAT Full view | Length255 | Functional ClassificationIb | DiseaseMetabolic | BrandPulmozyme | CompanyGenentech Inc | Physical AppearanceN.A. | Route of AdministartionAdministered by inhalation of an aerosol mist produced by a compressed air driven nebulizer system | CategoryEnzymes | TargetDNA |
ID1023 | ThPPIDTh1003 | NameDornase alfa | Peptide SequenceLKIAAFNIQTFGETKMSNAT Full view | Length255 | Functional ClassificationIb | DiseaseMetabolic | BrandViscozyme | CompanyRoche (Chile) | Physical AppearanceN.A. | Route of AdministartionAdministered by inhalation of an aerosol mist produced by a compressed air driven nebulizer system | CategoryEnzymes | TargetDNA |
ID1602 | ThPPIDTh1128 | NameVelaglucerase Alfa | Peptide SequenceARPCIPKSFGYSSVVCVCNA Full view | Length497 | Functional ClassificationIa | DiseaseHormonal | BrandVPRIV | CompanyShire | Physical AppearanceSterile, preservative free, lyophilized powder | Route of AdministartionIntravenous infusion | CategoryEnzymes | TargetGlucosylceramidase |
ID1608 | ThPPIDTh1131 | NameTaliglucerase Alfa | Peptide SequenceEFARPCIPKSFGYSSVVCVC Full view | Length504 | Functional ClassificationIa | DiseaseHormonal | BrandElelyso | CompanyPfizer | Physical AppearanceSterile, non-pyrogenic, lyophilized product. | Route of AdministartionIntravenous infusion | CategoryEnzymes | TargetGlucocerebroside |
ID1621 | ThPPIDTh1134 | NameAsparaginase Erwinia Chrysanthemi | Peptide SequenceADKLPNIVILATGGTIAGSA Full view | Length327 | Functional ClassificationIc | DiseaseHormonal | BrandErwinaze | CompanyEUSA Pharma | Physical AppearanceSterile, lyophilized, white powder in vials. | Route of AdministartionIntramuscular injection | CategoryEnzymes | TargetN.A. |
ID1623 | ThPPIDTh1136 | NameGlucarpidase | Peptide SequenceALAQKRDNVLFQAATDEQPA Full view | Length393 | Functional ClassificationIc | DiseaseHormonal | BrandVoraxaze | CompanyBTG International | Physical AppearanceSterile, preservative-free, white lyophilized powder in single-use vials | Route of AdministartionIntravenous injection | CategoryEnzymes | TargetMethotrexate |
ID1694 | ThPPIDTh1166 | NameAsfotase Alfa | Peptide SequenceLVPEKEKDPKYWRDQAQETL Full view | Length726 | Functional ClassificationIa | DiseaseGenetic Disorders | BrandStrensiq | CompanyAlexion Pharma Ghbh | Physical AppearanceSolution | Route of AdministartionSubcutaneous | CategoryEnzymes Alimentary Tract and Metabolism | TargetSphingosine 1-phosphate receptor 1; Pyrophosphate |
ID1695 | ThPPIDTh1166 | NameAsfotase Alfa | Peptide SequenceLVPEKEKDPKYWRDQAQETL Full view | Length726 | Functional ClassificationIa | DiseaseGenetic Disorders | BrandStrensiq | CompanyAlexion Pharmaceuticals Inc. | Physical AppearanceSolution | Route of AdministartionSubcutaneous | CategoryEnzymes Alimentary Tract and Metabolism | TargetSphingosine 1-phosphate receptor 1; Pyrophosphate |
ID1736 | ThPPIDTh1177 | NameElosulfase alfa | Peptide SequenceAPQPPNILLLLMDDMGWGDL Full view | Length496 | Functional ClassificationIa | DiseaseMetabolic Disorders | BrandVimizim | CompanyBiomarin International Limited | Physical AppearanceSolution | Route of AdministartionIntravenous | CategoryEnzymes; Alimentary Tract and Metabolism | TargetN-acetylgalactosamine-6-sulfatase |
ID1803 | ThPPIDTh1197 | NameSebelipase alfa | Peptide SequenceSGGKLTAVDPETNMNVSEII Full view | Length378 | Functional ClassificationIa | DiseaseGenetic Disorders | BrandKanuma | CompanyAlexion Pharmaceuticals, Inc. | Physical AppearanceAqueous Solution | Route of AdministartionIntravenous infusion | CategoryEnzymes | TargetNA |
ID1804 | ThPPIDTh1198 | NameSacrosidase | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseGenetic Disorders | BrandSucraid | CompanyQOL Medical, LLC | Physical AppearanceSolution | Route of AdministartionOral | CategoryEnzymes | TargetNA |
ID1845 | ThPPIDTh1233 | NamePegloticase | Peptide SequenceTYKKNDEVEFVRTGYGKDMI Full view | Length298 | Functional ClassificationIb | DiseaseOsteological Disorders | BrandPegloticase (Krystexxa) | CompanyNA | Physical AppearanceSolid | Route of AdministartionIntravenous | CategoryEnzymes | TargetUric acid |